Decision 2002/188 - 2002/188/JHA: Council Decision of 28 February 2002 concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA

Please note

This page contains a limited version of this dossier in the EU Monitor.

1.

Current status

This decision has been published on March  6, 2002 and should have been implemented in national regulation on March  7, 2002 at the latest.

2.

Key information

official title

2002/188/JHA: Council Decision of 28 February 2002 concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA
 
Legal instrument Decision
Number legal act Decision 2002/188
Original proposal COM(2001)734 EN
CELEX number i 32002D0188

3.

Key dates

Document 28-02-2002
Publication in Official Journal 06-03-2002; Special edition in Slovak: Chapter 19 Volume 004,Special edition in Latvian: Chapter 19 Volume 004,Special edition in Bulgarian: Chapter 19 Volume 003,Special edition in Slovenian: Chapter 19 Volume 004,Special edition in Czech: Chapter 19 Volume 004,Special edition in Croatian: Chapter 19 Volume 016,Special edition in Maltese: Chapter 19 Volume 004,Special edition in Hungarian: Chapter 19 Volume 004,Special edition in Polish: Chapter 19 Volume 004,OJ L 63, 6.3.2002,Special edition in Romanian: Chapter 19 Volume 003,Special edition in Lithuanian: Chapter 19 Volume 004,Special edition in Estonian: Chapter 19 Volume 004
Effect 07-03-2002; Takes effect Date pub. + 1 See Art 3
End of validity 31-12-9999

4.

Legislative text

Avis juridique important

|

5.

32002D0188

2002/188/JHA: Council Decision of 28 February 2002 concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA

Official Journal L 063 , 06/03/2002 P. 0014 - 0014

Council Decision

of 28 February 2002

concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA

(2002/188/JHA)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union,

Having regard to Joint Action 97/396/JHA of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs(1), and in particular Article 5(1) thereof,

Having regard to the initiative of the Commission,

Whereas:

  • (1) 
    A risk assessment report on PMMA (paramethoxymethylamphetamine or N-methyl-1-(4-methoxyphenyl)-2-aminopropane) was drawn up, on the basis of Article 4(3) of Joint Action 97/396/JHA, at a meeting convened under the auspices of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction.
  • (2) 
    At present, PMMA is controlled under the national drugs legislation in four Member States.
  • (3) 
    PMMA is not currently listed in any of the Schedules to the 1971 United Nations Convention on Psychotropic Substances. PMMA poses health risks for individuals and could pose a threat to public health. PMMA is an amphetamine analogue very close to PMA which is included in Schedule I to the 1971 United Nations Convention. PMMA has no therapeutic value.
  • (4) 
    Within the European Union, PMMA has always been consumed with PMA in tablets taken as "ecstasy" (MDMA). There is no explicit consumer market for either PMMA or PMA.
  • (5) 
    PMMA has been associated in combination with PMA with three deaths within the European Community. Experiments on animals indicate that there is a narrow margin between the behaviourally active and lethal dose of PMMA and therefore a high risk of acute toxicity exists. PMMA seems to have a similar toxicity to PMA and MDMA.
  • (6) 
    Trafficking and distribution of PMMA have taken place in four Member States and three of these have information on the role of organised crime in the trafficking of PMMA/PMA. 18870 tablets containing PMMA have been seized in 29 incidents. Large scale production of PMMA does not take place in the European Union. Two laboratories have been seized in countries of Eastern Europe and production is believed to continue there.
  • (7) 
    PMMA should be subjected by the Member States to control measures and criminal penalties, as provided for under their legislation complying with their obligations under the 1971 United Nations Convention on Psychotropic Substances with respect to substances listed in Schedules I or II thereto,

HAS DECIDED AS FOLLOWS:

Article 1

Member States shall take the necessary measures, in accordance with their national law, to submit PMMA (paramethoxymethylamphetamine or N-methyl-1-(4-methoxyphenyl)-2-aminopropane), to control measures and criminal penalties, as provided for under their legislation complying with their obligations under the 1971 United Nations Convention on Psychotropic Substances with respect to substances listed in Schedules I or II thereto.

Article 2

Member States shall, in accordance with the third subparagraph of Article 5(1) of Joint Action 97/396/JHA, take the measures referred to in Article 1 within three months of the date on which this Decision takes effect. Within six months of the date on which this Decision takes effect, Member States shall inform the Secretariat General of the Council and the Commission of the measures they have taken.

Article 3

This Decision shall be published in the Official Journal. It shall take effect on the day following its publication.

Done at Brussels, 28 February 2002.

For the Council

The President

  • A. 
    Acebes Paniagua
  • (1) 
    OJ L 167, 25.6.1997, p....

More

This text has been adopted from EUR-Lex.

6.

Original proposal

 

7.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

8.

Full version

This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

9.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.